查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1703237

2025年全球冠状动脉支架市场报告

Coronary Stents Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年冠状动脉支架市场规模将强劲成长。到 2029 年，这一数字将成长至 165 亿美元，复合年增长率为 8.3%。预测期内的增长可归因于心血管疾病盛行率的上升、人口老化、心血管健康意识的增强、政府援助计划和资金以及文明病盛行率的上升。预测期内的关键趋势包括支架技术创新、成像技术创新、策略联盟和伙伴关係关係、支架材料创新以及与数位健康的技术融合。

心血管疾病（CVD）盛行率的上升预计将推动冠状动脉支架市场的扩张。 CVD 包括一系列心臟和血管疾病，包括冠状动脉疾病、心臟衰竭、中风和高血压。心血管疾病的增加是由于人口老化以及肥胖、糖尿病、久坐的生活方式、不良饮食和压力等风险因素的增加。冠状动脉支架在心血管疾病的治疗中至关重要，因为它们可以打开冠状动脉的狭窄或阻塞，改善心臟的血液流动并降低心臟病发作的风险。例如，美国心臟学会2022年8月发布的报告预测，2025年至2060年美国心血管危险因子将大幅增加，其中糖尿病患者将增加39.3%至5500万人，血脂异常症将增加27.6%至1.26亿人，高血压患者将增加25.1%至1.62亿人，肥胖患者将增加1.3%。增幅最大的是中风（增加 33.8% 至 1500 万人）和心臟衰竭（增加 33.4% 至 1300 万人），缺血性心臟疾病和心臟病发作也大幅增加。心血管疾病盛行率的上升推动了冠状动脉支架的需求。

冠状动脉支架市场的公司正专注于开发药物释放型支架等先进产品，以尽量减少与传统裸金属支架相比再次手术的需要。药物释放型支架是一种涂有药物的特殊装置，可以缓慢释放药物以防止动脉再次变窄。例如，2024年5月，美国医疗保健公司雅培在印度推出了其XIENCE Sierra艾诺莉茉斯冠状动脉涂药支架系统。该支架具有增强的设计、新颖的输送系统和独特的尺寸选择，以适应复杂的适应症。与其他XIENCE支架一样，该支架涂有特殊涂层，可降低动脉再次阻塞的风险，并拥有超过120项临床试验（涉及超过120,000名患者）支持的强大安全记录。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球冠状动脉支架市场 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球冠状动脉支架市场：成长率分析
  • 全球冠状动脉支架市场表现：规模与成长，2019-2024
  • 全球冠状动脉支架市场预测：规模与成长，2024-2029，2034F
  • 全球冠状动脉支架总目标市场（TAM）

第六章市场区隔

  • 全球冠状动脉支架市场：按产品类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 双疗法支架
  • 放射性支架
  • 血栓切除支架
  • 覆膜支架
  • 生物可吸收支架
  • 生物分解性支架
  • 混合支架
  • 药物释放型支架
  • 裸金属支架
  • 全球冠状动脉支架市场技术、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 雷射切割
  • 3D列印支架
  • 微加工
  • 基于奈米技术的支架
  • 电解抛光
  • 其他技术
  • 全球冠状动脉支架市场（按原始材料、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 钴铬合金
  • 不銹钢
  • 铂铬
  • 镍钛合金
  • 聚合物
  • 全球冠状动脉支架市场：按部署、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 自动扩张型支架
  • 球囊扩张型支架
  • 全球冠状动脉支架市场最终用途、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 医院及门诊手术中心
  • 专科诊所
  • 其他用途
  • 全球冠状动脉支架市场、双疗法支架类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • Sirolimus洗脱双疗支架
  • 紫杉醇洗脱双疗支架
  • Everolimus洗脱双疗支架
  • 全球冠状动脉支架市场依放射性支架类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • β射线支架
  • 伽玛射线支架
  • 其他放射性支架
  • 全球冠状动脉支架市场细分（依血栓切除支架类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 手动血栓切除支架
  • 机械血栓切除支架
  • 动态血栓切除支架
  • 全球冠状动脉支架市场细分（依覆膜支架类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • PTFE涂层支架
  • ePTFE覆膜支架
  • 聚氨酯涂层支架
  • 其他覆膜支架
  • 全球冠状动脉支架市场，按生物可吸收支架类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 聚合物基生物可吸收支架
  • 金属基生物可吸收支架
  • 陶瓷基生物可吸收支架
  • 全球冠状动脉支架市场生物分解性支架类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 聚合物生物分解性支架
  • 镁基生物分解性支架
  • 其他生物分解性支架
  • 全球冠状动脉支架市场混合支架类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 混合药物释放型支架
  • 混合生物分解性或金属支架
  • 其他混合支架
  • 全球冠状动脉支架市场细分（按药物释放型支架类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • Sirolimus洗脱支架
  • 紫杉醇洗脱支架
  • Everolimus洗脱支架
  • 佐他莫司洗脱支架
  • 其他药物释放型支架
  • 全球冠状动脉支架市场裸金属支架细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 不銹钢裸金属支架
  • 钴铬裸金属支架
  • 其他裸金属支架

第七章 区域和国家分析

  • 全球冠状动脉支架市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球冠状动脉支架市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 冠状动脉支架市场：竞争格局
  • 冠状动脉支架市场：公司简介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Biosensors International Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Terumo Corporation
  • WL Gore & Associates Inc.
  • Cook Medical Inc.
  • BIOTRONIK SE & Co. KG
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich
  • Asahi Intecc Co. Ltd.
  • Sahajanand Medical Technologies Limited
  • Translumina GmbH
  • Stentys SA
  • Sorin Group
  • InspireMD Inc.
  • CR Bard Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年冠状动脉支架市场：提供新机会的国家
  • 2029年冠状动脉支架市场：细分市场带来新机会
  • 2029年冠状动脉支架市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r29898

Coronary stents are small, expandable tubes used to open narrowed or blocked coronary arteries, which supply blood to the heart muscle. Typically constructed from metal mesh, these devices are inserted during a procedure known as percutaneous coronary intervention (PCI) or angioplasty. The stent is delivered via a balloon catheter and expanded at the blockage site to restore proper blood flow.

The main types of coronary stents include dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents integrate drug-eluting and bioresorbable technologies to offer both medication release and gradual absorption of the stent structure. Various technologies used in their manufacture include laser cutting, 3D printing, microfabrication, nanotechnology, and electropolishing. Materials used in stent production can include cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. Stents can be self-expandable or balloon-expandable and are utilized by hospitals, ambulatory surgical centers, specialty clinics, and other healthcare facilities.

The coronary stents market research report is one of a series of new reports from The Business Research Company that provides coronary stents market statistics, including coronary stents industry global market size, regional shares, competitors with a coronary stents market share, detailed coronary stents market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. This coronary stents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coronary stents market size has grown strongly in recent years. It will grow from $11.06 billion in 2024 to $12.02 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to growing preference for minimally invasive procedures, expansion of healthcare access in emerging markets, rising healthcare expenditure, increase in percutaneous coronary interventions, growing number of cardiologists.

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $16.5 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing incidence of cardiovascular diseases, aging population, rising awareness about cardiovascular health, supportive government programs and funding, growing incidence of lifestyle diseases. Major trends in the forecast period include innovations in stent technology, innovations in imaging technologies, strategic collaborations and partnerships, innovations in stent materials, technological integration with digital health.

The growing prevalence of cardiovascular diseases (CVDs) is anticipated to drive the expansion of the coronary stent market. CVDs encompass a range of heart and blood vessel disorders, including coronary artery disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is attributed to factors such as an aging population, increased rates of risk factors such as obesity, diabetes, sedentary lifestyles, poor diet, and stress. Coronary stents are crucial in treating CVDs as they help open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For example, a report from the American College of Cardiology in August 2022 projected significant increases in cardiovascular risk factors in the U.S. from 2025 to 2060. It predicted a 39.3% increase in diabetes cases to 55 million, a 27.6% rise in dyslipidemia to 126 million, a 25.1% increase in hypertension to 162 million, and an 18.3% rise in obesity to 126 million. The most notable increases are expected in stroke (33.8% rise to 15 million) and heart failure (33.4% rise to 13 million), with ischemic heart disease and heart attacks also showing substantial growth. This rising prevalence of CVDs is driving the demand for coronary stents.

Companies in the coronary stent market are focusing on developing advanced products such as drug-eluting stents to minimize the need for repeat procedures compared to traditional bare-metal stents. Drug-eluting stents are specialized devices coated with medication that gradually releases drugs to prevent the re-narrowing of arteries. For instance, in May 2024, Abbott, a US-based healthcare company, introduced the XIENCE Sierra Everolimus Eluting Coronary Stent System in India. This stent features an enhanced design, a new delivery system, and unique size options tailored for complex cases. It maintains a specialized coating to reduce the risk of artery re-blockage, consistent with other XIENCE stents, and boasts a strong safety record supported by over 120 clinical trials involving more than 120,000 patients.

In October 2022, Cordis, a US-based developer of cardiovascular and endovascular devices, acquired MedAlliance for an undisclosed amount. This acquisition will enable Cordis to reach two million patients globally by 2027 with the SELUTION SLR (Sustained Limus Release) drug-eluting balloon. Cordis will also co-promote MedAlliance's SELUTION SLR drug-eluting balloon in existing markets. MedAlliance is a Switzerland-based manufacturer of coronary stents.

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

North America was the largest region in the coronary stents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coronary stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coronary Stents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronary stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for coronary stents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronary stents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Dual Therapy Stents; Radioactive Stents; Thrombectomy Stents; Covered Stents; Bioresorbable Stents; Biodegradable Stents; Hybrid Stents; Drug-Eluting Stents; Bare Metal Stents
  • 2) By Technology: Laser Cutting; 3D-Printed Stents; Microfabrication; Nanotechnology-Based Stents; Electropolishing; Others Technologies
  • 3) By Raw Material: Cobalt-Chromium; Stainless Steel; Platinum-Chromium; Nickel-Titanium; Polymer
  • 4) By Deployment: Self-Expandable Stents; Balloon-Expandable Stents
  • 5) By End Uses: Hospitals And Ambulatory Surgical Centers; Specialty Clinics; Other End Uses
  • Subsegments:
  • 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents; Paclitaxel-Eluting Dual Therapy Stents; Everolimus-Eluting Dual Therapy Stents
  • 2) By Radioactive Stents: Beta Radiation Stents; Gamma Radiation Stents; Other Radiation Stents
  • 3) By Thrombectomy Stents: Manual Thrombectomy Stents; Mechanical Thrombectomy Stents; Hydrodynamic Thrombectomy Stents
  • 4) By Covered Stents: PTFE-Covered Stents; ePTFE-Covered Stents; Polyurethane-Covered Stents; Other Covered Stents
  • 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents; Metal-Based Bioresorbable Stents; Ceramic-Based Bioresorbable Stents
  • 6) By Biodegradable Stents: Polymeric Biodegradable Stents; Magnesium-Based Biodegradable Stents; Other Biodegradable Stents
  • 7) By Hybrid Stents: Hybrid Drug-Eluting Stents; Hybrid Biodegradable Or Metal Stents; Other Hybrid Stents
  • 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents; Paclitaxel-Eluting Stents; Everolimus-Eluting Stents; Zotarolimus-Eluting Stents; Other Drug-Eluting Stents
  • 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents; Cobalt Chromium Bare Metal Stents; Other Bare Metal Stents
  • Companies Mentioned: Abbott Laboratories; Medtronic Plc; Biosensors International Group Ltd.; Boston Scientific Corporation; B. Braun Melsungen AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Coronary Stents Market Characteristics

3. Coronary Stents Market Trends And Strategies

4. Coronary Stents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Coronary Stents Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Coronary Stents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Coronary Stents Market Growth Rate Analysis
  • 5.4. Global Coronary Stents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Coronary Stents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Coronary Stents Total Addressable Market (TAM)

6. Coronary Stents Market Segmentation

  • 6.1. Global Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dual Therapy Stents
  • Radioactive Stents
  • Thrombectomy Stents
  • Covered Stents
  • Bioresorbable Stents
  • Biodegradable Stents
  • Hybrid Stents
  • Drug-Eluting Stents
  • Bare Metal Stents
  • 6.2. Global Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laser Cutting
  • 3D-Printed Stents
  • Microfabrication
  • Nanotechnology-Based Stents
  • Electropolishing
  • Others Technologies
  • 6.3. Global Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cobalt-Chromium
  • Stainless Steel
  • Platinum-Chromium
  • Nickel-Titanium
  • Polymer
  • 6.4. Global Coronary Stents Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Self-Expandable Stents
  • Balloon-Expandable Stents
  • 6.5. Global Coronary Stents Market, Segmentation By End Uses, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Ambulatory Surgical Centers
  • Specialty Clinics
  • Other End Uses
  • 6.6. Global Coronary Stents Market, Sub-Segmentation Of Dual Therapy Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sirolimus-Eluting Dual Therapy Stents
  • Paclitaxel-Eluting Dual Therapy Stents
  • Everolimus-Eluting Dual Therapy Stents
  • 6.7. Global Coronary Stents Market, Sub-Segmentation Of Radioactive Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Beta Radiation Stents
  • Gamma Radiation Stents
  • Other Radiation Stents
  • 6.8. Global Coronary Stents Market, Sub-Segmentation Of Thrombectomy Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Thrombectomy Stents
  • Mechanical Thrombectomy Stents
  • Hydrodynamic Thrombectomy Stents
  • 6.9. Global Coronary Stents Market, Sub-Segmentation Of Covered Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PTFE-Covered Stents
  • ePTFE-Covered Stents
  • Polyurethane-Covered Stents
  • Other Covered Stents
  • 6.10. Global Coronary Stents Market, Sub-Segmentation Of Bioresorbable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymer-Based Bioresorbable Stents
  • Metal-Based Bioresorbable Stents
  • Ceramic-Based Bioresorbable Stents
  • 6.11. Global Coronary Stents Market, Sub-Segmentation Of Biodegradable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymeric Biodegradable Stents
  • Magnesium-Based Biodegradable Stents
  • Other Biodegradable Stents
  • 6.12. Global Coronary Stents Market, Sub-Segmentation Of Hybrid Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hybrid Drug-Eluting Stents
  • Hybrid Biodegradable Or Metal Stents
  • Other Hybrid Stents
  • 6.13. Global Coronary Stents Market, Sub-Segmentation Of Drug-Eluting Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sirolimus-Eluting Stents
  • Paclitaxel-Eluting Stents
  • Everolimus-Eluting Stents
  • Zotarolimus-Eluting Stents
  • Other Drug-Eluting Stents
  • 6.14. Global Coronary Stents Market, Sub-Segmentation Of Bare Metal Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stainless Steel Bare Metal Stents
  • Cobalt Chromium Bare Metal Stents
  • Other Bare Metal Stents

7. Coronary Stents Market Regional And Country Analysis

  • 7.1. Global Coronary Stents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Coronary Stents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Coronary Stents Market

  • 8.1. Asia-Pacific Coronary Stents Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Coronary Stents Market

  • 9.1. China Coronary Stents Market Overview
  • 9.2. China Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Coronary Stents Market

  • 10.1. India Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Coronary Stents Market

  • 11.1. Japan Coronary Stents Market Overview
  • 11.2. Japan Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Coronary Stents Market

  • 12.1. Australia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Coronary Stents Market

  • 13.1. Indonesia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Coronary Stents Market

  • 14.1. South Korea Coronary Stents Market Overview
  • 14.2. South Korea Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Coronary Stents Market

  • 15.1. Western Europe Coronary Stents Market Overview
  • 15.2. Western Europe Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Coronary Stents Market

  • 16.1. UK Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Coronary Stents Market

  • 17.1. Germany Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Coronary Stents Market

  • 18.1. France Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Coronary Stents Market

  • 19.1. Italy Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Coronary Stents Market

  • 20.1. Spain Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Coronary Stents Market

  • 21.1. Eastern Europe Coronary Stents Market Overview
  • 21.2. Eastern Europe Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Coronary Stents Market

  • 22.1. Russia Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Coronary Stents Market

  • 23.1. North America Coronary Stents Market Overview
  • 23.2. North America Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Coronary Stents Market

  • 24.1. USA Coronary Stents Market Overview
  • 24.2. USA Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Coronary Stents Market

  • 25.1. Canada Coronary Stents Market Overview
  • 25.2. Canada Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Coronary Stents Market

  • 26.1. South America Coronary Stents Market Overview
  • 26.2. South America Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Coronary Stents Market

  • 27.1. Brazil Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Coronary Stents Market

  • 28.1. Middle East Coronary Stents Market Overview
  • 28.2. Middle East Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Coronary Stents Market

  • 29.1. Africa Coronary Stents Market Overview
  • 29.2. Africa Coronary Stents Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Coronary Stents Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Coronary Stents Market, Segmentation By Raw Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Coronary Stents Market Competitive Landscape And Company Profiles

  • 30.1. Coronary Stents Market Competitive Landscape
  • 30.2. Coronary Stents Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Biosensors International Group Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Coronary Stents Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. W. L. Gore & Associates Inc.
  • 31.3. Cook Medical Inc.
  • 31.4. BIOTRONIK SE & Co. KG
  • 31.5. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.6. Meril Life Sciences Pvt. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. OrbusNeich
  • 31.9. Asahi Intecc Co. Ltd.
  • 31.10. Sahajanand Medical Technologies Limited
  • 31.11. Translumina GmbH
  • 31.12. Stentys S.A.
  • 31.13. Sorin Group
  • 31.14. InspireMD Inc.
  • 31.15. C. R. Bard Inc.

32. Global Coronary Stents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Coronary Stents Market

34. Recent Developments In The Coronary Stents Market

35. Coronary Stents Market High Potential Countries, Segments and Strategies

  • 35.1 Coronary Stents Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Coronary Stents Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Coronary Stents Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer